STAGE IV UVEAL MELANOMA AJCC V7
Clinical trials for STAGE IV UVEAL MELANOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV UVEAL MELANOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV UVEAL MELANOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double immunotherapy plus liver blockade targets eye cancer that spreads
Disease control CompletedThis trial investigates whether combining two immunotherapy drugs (ipilimumab and nivolumab) with a procedure called immunoembolization can help people whose uveal melanoma has spread to the liver. The drugs help the immune system attack cancer cells, while immunoembolization cut…
Matched conditions: STAGE IV UVEAL MELANOMA AJCC V7
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Can a vaccine keep melanoma from coming back? large trial tests immune boosters
Disease control CompletedThis phase 3 trial tested whether a yeast-derived immune stimulant (GM-CSF) and a peptide vaccine, alone or together, could prevent melanoma from returning after surgery. 815 patients with no visible cancer after complete surgical removal of advanced melanoma were randomly assign…
Matched conditions: STAGE IV UVEAL MELANOMA AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC